Results 1 to 10 of about 10,088 (191)
Rifaximin alleviates irinotecan-induced diarrhea in mice model
Background Irinotecan is a chemotherapeutic drug widely used to treat solid tumors. However, its effectiveness is limited by the severely delayed onset of diarrhea.
Chengyi Huang +9 more
doaj +1 more source
Rifaximin is a poorly absorbable antibiotic against hepatic encephalopathy (HE). This observational study aimed to elucidate the effect of rifaximin on intestinal permeability and gut microbiota in patients with decompensated cirrhosis.
Kosuke Kaji +15 more
doaj +1 more source
Network Meta‐Analysis: Treatments for Acute Alcohol‐Associated Hepatitis
ABSTRACT Background Alcohol‐related hepatitis (AH) is an acute form of liver disease with a high short‐term mortality. A variety of treatments have been explored in randomised studies. Recent consensus on study outcomes has identified 90‐day survival as the primary outcome metric.
Charles Gallaher +7 more
wiley +1 more source
Rifaximin, a non-absorbable antibiotic used in managing recurrent hepatic encephalopathy (HE), has traditionally been considered low risk for inducing resistance.
Cheng-Hao Kuo +6 more
doaj +1 more source
Citicoline versus Rifaximin in Prevention of Recurrence of Hepatic Encephalopathy [PDF]
Background and study aims: Hepatic encephalopathy (HE) is a major neuropsychiatric complication of liver cirrhosis. Recurrent episodes significantly impair quality of life and increase hospitalization and mortality risks.
Mohammed Hussien Ahmed +5 more
doaj +1 more source
The intestinal microbiome is a key regulator of immune homeostasis, metabolism, and epithelial barrier integrity. In patients with malignant hematological diseases, particularly those undergoing hematopoietic stem cell transplantation, microbiome perturbations by reduced diversity, pathobiont expansion, and loss of beneficial metabolites are common as ...
Bálint Gergely Szabó +7 more
wiley +1 more source
Background. Rifaximin is effective in relieving pain symptoms with IBS patients, although the mechanisms were not clear. The aims of the research were to investigate whether the visceral hyperalgesia was alleviated by rifaximin via TRPV1 channel in rats.
Chang-qing Yang +6 more
doaj +1 more source
ABSTRACT Background Sarcopenia is common in cirrhosis and is associated with poor outcomes. We aimed to identify factors associated with longitudinal skeletal muscle loss and to explore estimation of future L3 skeletal muscle index (L3‐SMI) using routinely available clinical variables. Methods This retrospective longitudinal study included 175 patients
Suguru Miida +14 more
wiley +1 more source
Objectives: Rifaximin is a non-absorbable antibiotic that has an efficacy for hepatic encephalopathy (HE). We previously demonstrated that rifaximin improved liver functional reserve, but this was a single-center study with a limited number of cases, and
Kensuke Kitsugi +9 more
doaj +1 more source
ABSTRACT Background Persistent gas‐predominant dyspeptic symptoms affect many patients despite adequate proton pump inhibitor (PPI) therapy, reflecting mechanisms beyond acid secretion. We evaluated the real‐world effectiveness and safety of simethicone (80 mg) plus activated charcoal (250 mg) in adults with persistent symptoms despite prior PPI ...
Ashish Kumar +11 more
wiley +1 more source

